Figure 3.

Forest plot of random-effects meta-analysis of HCV RNA prevalence at baseline among gay and bisexual men using PrEP. n = number of participants positive for HCV RNA at study baseline; N = number of participants tested for HCV antibodies and/or RNA. The denominator for RNA prevalence is the number of study participants tested for HCV (either antibody or RNA) at baseline, as many study protocols only tested participants for RNA if they were antibody positive. Abbreviations: HCV, hepatitis C virus; PrEP, pre-exposure prophylaxis.